- Issuer ticker
-
RENB
- Reported as of
-
20 Feb 2024
- Net transaction value
-
+$250,000
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
22 Feb 2024, 16:35:47 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Rene Sindlev
Key filing fact
Rene Sindlev filed Form 4 for RENOVARO INC. (RENB) on 22 Feb 2024.
Key facts
- This page summarizes Rene Sindlev's Form 4 filing for RENOVARO INC. (RENB).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Feb 2024, 16:35.
Change
- Previous filing in this sequence was filed on 15 Feb 2024.
- Current net transaction value: +$250,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RENB
transaction
Common Stock
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $250,000
- Shares
- +471,699
- Change %
- +3.6%
- Price
-
$0.5300
- Shares after
- 13,605,297
- Date
- 20 Feb 2024
- Ownership
- By RS Bio ApS
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RENB
transaction
Derivative
Warrant (Right to Buy)
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $0
- Shares
- -471,699
- Change %
- -50%
- Price
-
$0.000000
- Shares after
- 471,698
- Date
- 20 Feb 2024
- Ownership
- By RS Bio ApS
- Underlying class
- Common Stock
- Underlying amount
- 471,699
- Exercise price
- $0.5300
* marks a reported price that did not pass the local price check.